INDENZA (Enzalutamide) is a novel androgen receptor inhibitor.
It works by blocking the action of male hormones that stimulate cancer growth.
Recommended for:
Men with metastatic castration-resistant prostate cancer
Patients who have failed previous chemotherapy or hormonal therapy
Use as monotherapy or in combination regimens
Metastatic castration-resistant prostate cancer
Progressive prostate cancer after hormonal treatment failure
The medicine is taken orally, with or without food, exactly as prescribed by a healthcare provider. Dosage adjustments should not be made without professional supervision.
Contraindications:
Known allergy to Enzalutamide
Severe liver impairment
Children and adolescents under 18 years
Side effects:
Fatigue, headaches
Hot flushes
Elevated blood pressure
Seizures in rare cases
